Steven Wang

Steven Wang is a Principal Scientist in Pharmaceutical Development at REVOLUTION Medicines since November 2021. Prior to this role, Steven served as a Senior Scientist II in Formulation Development at MyoKardia from July 2018 to November 2021. Steven's extensive experience in the pharmaceutical industry also includes a tenure as a Staff Scientist in Pharmaceutics and Manufacturing at Rigel Pharmaceuticals Inc. from October 2003 to July 2018.